Core Viewpoint - 康健国际医疗 collaborates with Pfizer Hong Kong to promote respiratory health education and provide 20-valent pneumococcal conjugate vaccines to underprivileged communities in Hong Kong [1][2] Group 1: Collaboration and Initiatives - 康健国际医疗, through its charity fund, donates a batch of 20-valent pneumococcal conjugate vaccines to the Tung Wah Group of Hospitals for community health protection [1] - The partnership aims to shift public health perception from "treatment-based" to "prevention-based" [1][2] - The extensive network of medical centers across Hong Kong will facilitate public access to the vaccines [1] Group 2: Public Health Impact - Pneumonia is the second leading cause of death in Hong Kong, with over 11,000 deaths in 2024, making it more lethal than heart disease and cerebrovascular diseases [4] - Pneumococcal infections pose a significant public health threat, particularly to the elderly and vulnerable populations [3][4] - Vaccination is highlighted as the most effective method to prevent pneumococcal diseases, significantly reducing the risk of invasive infections and severe outcomes [4] Group 3: Community Engagement - The Tung Wah Group of Hospitals will play a crucial role in distributing the donated vaccines and identifying suitable beneficiaries for vaccination [1][2] - The collaboration emphasizes the importance of community health investment and aims to alleviate the disease burden on vulnerable groups [3]

Group 1 - 康健国际医疗 collaborates with Pfizer Hong Kong to promote respiratory health education and donate 20-valent pneumococcal conjugate vaccines to underprivileged communities through the 康健慈善基金 [1] - The initiative aims to shift public health perspectives from "treatment-based" to "prevention-based" in response to the Hong Kong Department of Health's "Primary Healthcare Blueprint" [1] - The partnership with 东华三院 will ensure proper distribution of the donated vaccines to eligible individuals within the community [1][2] Group 2 - The chairman and CEO of 康健医疗 emphasized the public health threat posed by pneumococcal infections, particularly among the elderly and vulnerable groups, highlighting the urgency of respiratory health education [2] - According to the latest statistics from the Department of Health, pneumonia is the second leading cause of death in Hong Kong, with over 11,000 deaths in 2024, making it more lethal than heart disease and cerebrovascular diseases [4] - Vaccination against pneumococcal disease is identified as one of the most effective preventive measures, significantly reducing the risk of invasive infections and severe illness [4]